Market Participants Recognise GeneDx Holdings Corp.'s (NASDAQ:WGS) Revenues Pushing Shares 35% Higher
Despite an already strong run, GeneDx Holdings Corp. (NASDAQ:WGS) shares have been powering on, with a gain of 35% in the last thirty days. The last month tops off a massive increase of 293% in the
Insiders Buying GeneDx Holdings Might Wish They Invested More, Stock Gains 12%
Express News | GeneDx Expands Access To Rapid Whole Genome Sequencing In NICUs Through New Collaboration With Epic, Enhancing Integration With Health Systems Using Epic's EHR
Express News | GeneDx Announces Collaboration With Epic Aura to Expand Access to Rapid Whole Genome Sequencing (Rwgs) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
GeneDx Announces Collaboration With Epic Aura to Expand Access to Rapid Whole Genome Sequencing (RWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections ---- Increases commercial footprint and focus on accelerating
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$2.76 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 130K shares of common stock on Jun 3, 4, 2024 at an average price of $21.2086 for a total value of $2.76 million. This transacti
Institutional Investors Have a Lot Riding on GeneDx Holdings Corp. (NASDAQ:WGS) With 47% Ownership
Key Insights Significantly high institutional ownership implies GeneDx Holdings' stock price is sensitive to their trading actions The top 4 shareholders own 50% of the company Insiders have sold
Express News | GeneDx Announced The First-of-its-kind Patient Access Program, Developed In Partnership With Leading Biopharma Companies, Which Aims To Increase Access To Exome Sequencing For Pediatric Epilepsy Patients
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient acces
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$842.6K in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 40,000 shares of common stock on May 29, 2024 at an average price of $21.0651 for a total value of $842.6K. This transaction inv
Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$3.42 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 170K shares of common stock on May 23, 24, 28, 2024 at an average price of $20.147 for a total value of $3.42 million. This tran
GeneDx to Participate in Upcoming Investor Conferences
STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will partici
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
GeneDx Holdings(WGS.US) 10% Shareholder Buys US$1.17 Million in Common Stock
$GeneDx Holdings(WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 50,000 shares of common stock on May 13, 2024 at an average price of $23.3059 for a total value of $1.17 million. This transacti
Express News | GeneDx Shares Are Trading Higher After the Company on Tuesday Reported Better-than-expected Q1 Financial Results
Analysts Are Upgrading GeneDx Holdings Corp. (NASDAQ:WGS) After Its Latest Results
GeneDx Holdings Corp. (NASDAQ:WGS) just released its quarterly report and things are looking bullish. The results were impressive, with revenues of US$62m exceeding analyst forecasts by 26%, and
GeneDx Holdings First Quarter 2024 Earnings: Beats Expectations
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Tuesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) little changed, erasing earlier gains. The iShares Bi
No Data